Overview

* McKesson Corp ( MCK ) fiscal Q2 rev grows 10% yr/yr, slightly missing analyst expectations

* Adjusted EPS for fiscal Q2 beats consensus, rising 39% yr/yr

* Company raises fiscal 2026 adjusted EPS guidance, indicating confidence in growth strategy

Outlook

* McKesson raises fiscal 2026 adjusted EPS guidance to $38.35-$38.85, from the previous range of $38.05 to $38.55

* Company does not forecast GAAP earnings

* McKesson sees 16%-18% growth in fiscal 2026 adjusted EPS

Result Drivers

* NORTH AMERICAN PHARMACEUTICAL GROWTH - Revenue growth driven by increased prescription volumes from retail national account customers and specialty products

* ONCOLOGY & MULTISPECIALTY SEGMENT - Segment revenue increased 32% due to provider and specialty distribution growth and acquisitions

* ADJUSTED EPS DRIVERS - Increase driven by operational growth, net gains from investments, and lower tax rate

Key Details

Metric Beat/Mis Actual Consensu

s s

Estimate

Q2 Slight $103.15 $104.13

Revenue Miss* bln bln (13

Analysts

)

Q2 Beat $9.86 $9.04

Adjusted (14

EPS Analysts

)

Q2 EPS $8.92

Q2 Beat $1.23 $1.12

Adjusted bln bln (11

Net Analysts

Income )

*Applies to a deviation of less than 1%; not applicable for per-share numbers.

Analyst Coverage

* The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 15 "strong buy" or "buy", 3 "hold" and no "sell" or "strong sell"

* The average consensus recommendation for the pharmaceuticals peer group is "buy"

* Wall Street's median 12-month price target for McKesson Corp ( MCK ) is $856.50, about 1.7% above its November 4 closing price of $841.67

* The stock recently traded at 20 times the next 12-month earnings vs. a P/E of 18 three months ago

For questions concerning the data in this report, contact [email protected]. For any other questions or feedback, contact .

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)